Erratum (DOI:10.1053/j.ajkd.2008.08.035);Prevalence and Awareness of CKD Among African Americans: The Jackson Heart Study

American Journal of Kidney Diseases

Volumn 53, Issue 2, 2009, Pages 238-247

  Flessner, Michael F ^a   Wyatt, Sharon B ^a,b   Akylbekova, Ermeg L ^a,c   Coady, Sean ^d   Fulop, Tibor ^a   Lee, Frederick ^a   Taylor, Herman A ^a   Crook, Errol ^e  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c JACKSON STATE UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

African American; chronic disease; epidemiology; population; proteinuria; Renal insufficiency

Indexed keywords

ADULT; AFRICAN AMERICAN; AGING; ALBUMINURIA; ANAMNESIS; ANTHROPOMETRY; ARTICLE; AWARENESS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE ACCESS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; RENAL REPLACEMENT THERAPY; SOCIOECONOMICS; URINALYSIS; WAIST CIRCUMFERENCE;

EID: 58249114247     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.020     Document Type: Erratum

References (32)

1. Dirks J.H., De Z.D., Agarwal S.K., and Atkins R.C. Prevention of chronic kidney and vascular disease: Toward global health equity-The Bellagio 2004 Declaration. Kidney Int 68 suppl 98 (2005) S1-S6
2. Lysaght M.J. Maintenance dialysis population dynamics: Current trends and long-term implications. Kidney Int 68 suppl 98 (2005) S37-S40
3. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
4. Saydah S., Eberhardt M., Rios-Burrows N., Williams D., Geiss L., and Dorsey R. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morbid Mortal Wkly Rep 56 (2007) 161-165
5. Collins A., Kasiske B., Herzog C., et al. 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Am J Kidney Dis 49 suppl 1 (2007) S10-S223
6. Schieppati A., and Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social, and economic implications. Kidney Int 68 suppl 98 (2005) S7-S10
7. Bello A.K., Nwankwo E., and El Nahas A.M. Prevention of chronic kidney disease: A global challenge. Kidney Int 68 suppl 98 (2005) S11-S17
8. de Zeeuw D., Remuzzi G., Parving H.H., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110 (2004) 921-927
9. de Zeeuw D., Lewis E.J., Remuzzi G., Brenner B.M., and Cooper M.E. Renoprotective effects of renin-angiotensin-system inhibitors. Lancet 367 (2006) 899-900
10. Eijkelkamp W.B., Zhang Z., Remuzzi G., et al. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 18 (2007) 1540-1546
11. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., and Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345 (2001) 870-878
12. Taylor H.A., Hughes G.D., and Garrison R.J. Cardiovascular disease among women residing in rural America: Epidemiology, explanations, and challenges. Am J Public Health 92 (2002) 548-551
13. Taylor Jr. H.A. Establishing a foundation for cardiovascular disease research in an African-American community-The Jackson Heart Study. Ethn Dis 13 (2003) 411-413
14. Wyatt S.B., Akylbekova E., Wofford M.R., et al. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension 51 (2008) 650-656
15. Taylor H., Liu J., Wilson G., et al. Distinct component profiles and high risk among African Americans with metabolic syndrome: The Jackson Heart Study. Diabetes Care 31 (2008) 1248-1253
16. Taylor Jr. H.A. The Jackson Heart Study: An overview. Ethn Dis 15 suppl 6 (2005) S1-S3
17. Fuqua S.R., Wyatt S.B., Andrew M.E., et al. Recruiting African-American research participation in the Jackson Heart Study: Methods, response rates, and sample description. Ethn Dis 15 suppl 6 (2005) S18-S29
18. Payne T.J., Wyatt S.B., Mosley T.H., et al. Sociocultural methods in the Jackson Heart Study: Conceptual and descriptive overview. Ethn Dis 15 suppl 6 (2005) S38-S48
19. Carpenter M.A., Crow R., Steffes M., et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 328 (2004) 131-144
20. National Committee for Clinical Laboratory Standards. Procedures and Devices for the Collection of Diagnostic Blood Specimens by Skin Puncture: Approved Standard. 4th ed. Vol 19 (1999), NCCLS, Wayne, PA
21. National Committee for Clinical Laboratory Standards. Urinalysis and Collection, Transportation, and Preservation of Urine Specimens: Approved Guideline. 2nd ed. Vol 21 (1999), NCCLS, Wayne, PA
22. National Committee for Clinical Laboratory Standards. Procedures for the Handling and Processing of Blood Specimens: Approved Guideline. 2nd ed. Vol 21 (1999), NCCLS, Wayne, PA
23. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
24. Levin A., and Rocco M. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 suppl 2 (2007) S1-S179
25. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W.F., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
26. Perkins B.A., Fiociello L.H., Ostrander B.E., et al. Microalbuminuria and the risk for early progressive renal function decline in type I diabetes. J Am Soc Nephrol 18 (2007) 1353-1361
27. Wilson J.G., Rotimi C.N., Ekunwe L., et al. Study design for genetic analysis in the Jackson Heart Study. Ethn Dis 15 suppl 6 (2005) S6-S37
28. Bryson C.L., Ross H.J., Boyko E.J., and Young B.A. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: Associations with diabetes and level of CKD. Am J Kidney Dis 48 (2006) 720-726
29. de Boer I.H., Astor B., Kramer H., et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the Multi-Ethnic Study of Atherosclerosis. Clin J Am Soc Nephrol 3 (2008) 125-132
30. Brown W.W., Peters R.M., Ohmit S.E., et al. Early detection of kidney disease in community settings: The Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42 (2003) 22-35
31. Hsu C.C., Hwang S.J., Wen C.P., et al. High prevalence and low awareness of CKD in Taiwan: A study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 48 (2006) 727-738
32. Collins A.J. 2006 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Am J Kidney Dis 49 suppl 1 (2007) S100-S104